Search research articles
Contact Us
Filters
Showing results (81-90 of 163) with videos related to
Page
of 17
Sort By:
British Medical Journal (Clinical Research Ed.)
|
June 8, 1985
Influence of insulin antibodies on pharmacokinetics and bioavailability of recombinant human and highly purified beef insulins in insulin dependent diabetics
R S Gray, P Cowan, U di Mario, et al.
Diabetologia
|
July 1, 1984
Insulin-anti-insulin complexes in diabetic women and their neonates
U Di Mario, F Fallucca, P Gargiulo, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
January 1, 1989
New parameters to monitor the progression of diabetic nephropathy
U Di Mario, S Morano, A Cancelli, et al.
Diabetologia
|
February 1, 1987
Immunology in diabetic pregnancy: activated T cells in diabetic mothers and neonates
U Di Mario, F Dotta, P Gargiulo, et al.
The Journal of Diabetic Complications
|
January 1, 1988
The selective elimination of anionic immunoglobulins as a parameter of kidney damage in diabetes and diabetic pregnancy
S Morano, A Cancelli, S Bacci, et al.
Diabetologia
|
September 1, 1995
GM2-1 pancreatic islet ganglioside: identification and characterization of a novel islet-specific molecule
F Dotta, M Previti, L Lenti, et al.
Acta Endocrinologica
|
March 1, 1990
Autoantibodies to insulin do appear in non-diabetic patients with autoimmune disorders: comparison with anti-immunoglobulin antibodies and other autoimmune phenomena
U Di Mario, R Perfetti, E Anastasi, et al.
BMC Medical Genetics
|
September 26, 2001
The G-308A variant of the Tumor Necrosis Factor-alpha (TNF-alpha) gene is not associated with obesity, insulin resistance and body fat distribution
S Romeo, F Sentinelli, F Capici, et al.
Diabetes
|
September 1, 1996
Autoimmunity to the GM2-1 islet ganglioside before and at the onset of type I diabetes
F Dotta, R Gianani, M Previti, et al.
Journal of Endocrinological Investigation
|
February 1, 1988
Quantitative immunological differences between newly diagnosed Graves' disease patients and relapsed patients
U Di Mario, F P Cavatorta, R Perfetti, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 163) with videos related to
Sort By:
Page
of 17
British Medical Journal (Clinical Research Ed.)
|
June 8, 1985
Influence of insulin antibodies on pharmacokinetics and bioavailability of recombinant human and highly purified beef insulins in insulin dependent diabetics
R S Gray, P Cowan, U di Mario, et al.
Diabetologia
|
July 1, 1984
Insulin-anti-insulin complexes in diabetic women and their neonates
U Di Mario, F Fallucca, P Gargiulo, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
January 1, 1989
New parameters to monitor the progression of diabetic nephropathy
U Di Mario, S Morano, A Cancelli, et al.
Diabetologia
|
February 1, 1987
Immunology in diabetic pregnancy: activated T cells in diabetic mothers and neonates
U Di Mario, F Dotta, P Gargiulo, et al.
The Journal of Diabetic Complications
|
January 1, 1988
The selective elimination of anionic immunoglobulins as a parameter of kidney damage in diabetes and diabetic pregnancy
S Morano, A Cancelli, S Bacci, et al.
Diabetologia
|
September 1, 1995
GM2-1 pancreatic islet ganglioside: identification and characterization of a novel islet-specific molecule
F Dotta, M Previti, L Lenti, et al.
Acta Endocrinologica
|
March 1, 1990
Autoantibodies to insulin do appear in non-diabetic patients with autoimmune disorders: comparison with anti-immunoglobulin antibodies and other autoimmune phenomena
U Di Mario, R Perfetti, E Anastasi, et al.
BMC Medical Genetics
|
September 26, 2001
The G-308A variant of the Tumor Necrosis Factor-alpha (TNF-alpha) gene is not associated with obesity, insulin resistance and body fat distribution
S Romeo, F Sentinelli, F Capici, et al.
Diabetes
|
September 1, 1996
Autoimmunity to the GM2-1 islet ganglioside before and at the onset of type I diabetes
F Dotta, R Gianani, M Previti, et al.
Journal of Endocrinological Investigation
|
February 1, 1988
Quantitative immunological differences between newly diagnosed Graves' disease patients and relapsed patients
U Di Mario, F P Cavatorta, R Perfetti, et al.
Page
of 17